Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Advanced Protein Technologies Corp. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and 1 distinct art unit. This profile indicates a highly focused prosecution effort on a single technical case. The presence of 1 pending office action suggests that the company's current intellectual property activity is concentrated on a specific innovation within the biotechnology and pharmaceutical fields.
KIEFER, DALTON EDWARD is the busiest examiner for the company. This examiner is handling 1 pending office action. With only 1 distinct examiner and 1 distinct art unit involved, the success of the current prosecution is entirely dependent on the review of this single official. This requires a strategy that is closely tailored to the examination style of KIEFER, DALTON EDWARD. The lack of other pending actions or examiners means that the company's current USPTO activity is centralized in this one matter within the Biotechnology & Pharmaceuticals area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIEFER, DALTON EDWARD | 1 | 83.3% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18864765 | METHOD FOR PRODUCING LACTO-N-TETRAOSE AND LACTO-N-NEOTETRAOSE USING CORYNEBACTERIUM GLUTAMICUM | KIEFER, DALTON EDWARD | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18864765 | METHOD FOR PRODUCING LACTO-N-TETRAOSE AND LACTO-N-NEOTETRAOSE USING CORYNEBACTERIUM GLUTAMICUM | KIEFER, DALTON EDWARD | 1652 | §102 | Non-Final OA | — | Pending | Nov 11, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial